stannic oxide has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanna, DH; R Saad, G | 1 |
| Chilo, J; Horvath, G; Lindblad, T | 1 |
2 other study(ies) available for stannic oxide and Cancer of Ovary
| Article | Year |
|---|---|
Induction of mitochondria mediated apoptosis in human ovarian cancer cells by folic acid coated tin oxide nanoparticles.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Female; Folic Acid; Humans; Male; Mitochondria; Nanoparticles; Ovarian Neoplasms; Rats; Rats, Wistar; Tin Compounds | 2021 |
Different volatile signals emitted by human ovarian carcinoma and healthy tissue.
Topics: Adenocarcinoma, Papillary; Algorithms; Biomarkers, Tumor; Early Diagnosis; Electric Impedance; Electrodes; Fallopian Tubes; Female; Humans; Myometrium; Odorants; Ovarian Neoplasms; Ovary; Pilot Projects; Postmenopause; Predictive Value of Tests; Semiconductors; Sensitivity and Specificity; Temperature; Tin Compounds; Volatile Organic Compounds | 2010 |